Accessible Search Form           Advanced Search

Denis B. Buxton, Ph.D.

To arrange an interview, please contact the NHLBI Communications Office at 301-496-4236 or nhlbi_news@nhlbi.nih.gov.

Dr. Denis Buxton LoRes jpeg
Denis B. Buxton, Ph.D.

High Res JPG file (3097 KB)

Biography

Denis B. Buxton, Ph.D., joined the National Heart, Lung, and Blood Institute (NHLBI) as a senior fellow in 1996. Dr. Buxton was appointed Assistant Director of the Heart Research Program in NHLBI's Division of Heart and Vascular Diseases in 2001 and a year later took on an additional role as a Health Science Administrator in the Institute's Bioengineering and Genomics Applications Group. In 2005, he was appointed Acting Director of the Heart Research Program. In 2006, he became Chief, Advanced Technologies & Surgery Branch in the Division of Cardiovascular Diseases. Currently Dr. Buxton is Associate Director of the Basic and Early Translational Research Program.

Dr. Buxton's areas of research interest are molecular imaging, nanotechnology, myocardial ischemia and reperfusion, and stem cell transplantation. Dr. Buxton earned a B.Sc. in biochemistry in 1977 at University College, London, UK. In 1980 he earned a Ph.D. in biochemistry from the same institution. Prior to joining NHLBI, Dr. Buxton served as a research instructor from 1983 to 1985 in the Department of Biochemistry, at the University of Texas Health Science Center, San Antonio. He then went on to the University of California, Los Angeles School of Medicine where he served as Associate Professor in the Department of Radiological Sciences from 1991-1992, followed by an Associate Professorship in the Department of Molecular and Medical Pharmacology from 1993 to 1996. The author or coauthor of 68 papers, book chapters, letters, and review articles, Dr. Buxton earned the NHLBI Director's Award 2005 and gave the 19th Annual William Burch Memorial Lecture at the 2005 meeting of the Association of University Cardiologists. He is a reviewer for several prestigious medical journals, including Circulation, Lancet, the American Journal of Physiology, the Journal of Biological Chemistry, and Cardiovascular Research, among others.

Areas of Expertise: Molecular imaging, nanotechnology, myocardial ischemia and reperfusion, and stem cell transplantation.


Dr. Buxton In the News

June 27, 2012 : Massachusetts General Hospital
Immune response to heart attack worsens atherosclerosis, increases future risk
An international team of researchers discovered that a heart attack doesn't just damage heart muscle tissue by cutting off its blood supply, it also sets off an inflammatory response that worsens underlying atherosclerosis, actively increasing the risk for a future heart attack. Study results were published in the journal Nature.

June 8, 2012 : Circulation Research
Support for cardiovascular cell therapy research at the National Heart, Lung, and Blood Institute
Denis B. Buxton, Ph.D., and Sonia Skarlatos, Ph.D., Division of Cardiovascular Sciences
Cell therapy approaches have great potential for preventing the development of heart failure after myocardial infarction (heart attack) and for treating patients with existing heart failure.

View all Dr. Buxton in the news articles

Last Updated: April 20, 2012

Twitter iconTwitter         Facebook iconFacebook         YouTube iconYouTube